Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Public ClinicalTrials.gov record NCT00285675. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Continuation Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to monitor the safety of continued DN-101 and docetaxel treatment for subjects previously enrolled in DN101-002 (ASCENT) or DN101-004 (NSCLC) Studies.
Study identification
- NCT ID
- NCT00285675
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 25 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Jan 2008 (Type not available)
- Last update posted
- May 31, 2006
2006 – 2008
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alta Bates Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | — |
| Kaiser Permanente Medical Group, Northern California | Vallejo | California | 94589 | — |
| Columbia Presbyterian Medical Center | New York | New York | 10032 | — |
| Piedmont Hematology Oncology Associates | Winston-Salem | North Carolina | 27103 | — |
| NW Kaiser Permanente Portland | Portland | Oregon | 97227 | — |
| Alta Bates Comprehensive Center | Portland | Oregon | 97239-3098 | — |
| Oregon Health & Science University | Portland | Oregon | 97239-3098 | — |
| University of Pittsburgh,William Copper Ambulatory Care, Pavillion Hellman Cancer Center | Pittsburgh | Pennsylvania | 15232-1305 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Northwest Cancer Specialists Vancouver Office | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00285675, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2006 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00285675 live on ClinicalTrials.gov.